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Private hospital giant 
Netcare claims that its 
former auditors, KPMG, 
cynically breached client 
privi lege by sharing det-
ailed information they had obtained 
from Netcare with the Competitions 
Commission – after silently agreeing to 
help the Commission with its probe.
Melanie da Costa, Director of Strategy 
and Policy at Netcare (and chairperson of 
the Hospital Association of South Africa), 
said that a KPMG team had spent three 
years helping Netcare prepare itself for the 
healthcare market inquiry. It had unfettered 
access to Netcare’s strategy, planning, 
competitive positioning and other business 
data. This auditing team then allegedly 
shared this data with another KPMG 
team, which had, unknown to Netcare, 
taken on the Competitions Commission 
advisory and data-gathering brief – raising 
serious conflict-of-interest issues. She said 
that the wrangle was between Netcare and 
KPMG, not the Competitions Commission, 
and that it was not a delaying tactic, as a 
KPMG executive claimed, adding: ‘We have 
nothing to hide – I can tell you that, hand 
on heart – KPMG are disingenuously trying 
to portray that, but it’s most definitely not 
the issue.’
Da Costa was referring to the ‘totally 
irresponsible’ accusation by KPMG’s head of 
legal services, Olaff Abraham van Niekerk, 
that Netcare’s court action was part of an 
‘Operation Kotov’ (a chess move allegedly 
designed to delay the opponent, in this case 
ostensibly the Commission, thus hurrying 
them into a blunder). She said that when 
KPMG refused to provide Netcare with 
assurances that it would abide by accepted 
confidentiality rules, Netcare took them to 
court. On 29 October last year, the High 
Court in Gauteng ordered all KPMG staff 
assisting the Competitions Commission to 
provide ‘affidavits of assurance’ that KPMG’s 
internal ‘Chinese walls’ had not been 
breached – in other words, to swear under 
oath that they had not breached confidence 
by obtaining privileged information from 
their colleagues who worked for Netcare. 
Da Costa said that KPMG belatedly provided 
Netcare with these affidavits in December 
last year – revealing that its staff had in 
fact breached the court order. She claims 
that KPMG had up to 50 000 documents 
referencing Netcare (which KPMG refused 
to hand over). Far from Netcare stalling any 
Competitions Commission probe, it was 
KPMG who on 6 January this year requested 
a court postponement to 20 May.
Simple solution – hand 
over info to independent 
attorneys, says Netcare
‘They could have, and still can at any 
stage, give independent attorneys access to 
the information they have on Netcare to 
ensure this matter is speedily resolved, but 
have chosen not to,’ Da Costa emphasised. 
Netcare is asking the High Court to rule 
that: (i) KPMG breached its earlier ruling; 
(ii) KPMG hand over all relevant documents 
to independent attorneys to assess their 
content; and (iii) KPMG cease all work 
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for the Competitions Commission until the 
issue is resolved.
KPMG’s Van Niekerk claimed in court 
papers that Netcare went to court ‘as part 
of Operation Kotov’, adding: ‘Project Kotov 
seems a very apt name ... Kotov is a Russian 
surname, the most famous bearer of which 
was one Alexander Kotov. He was a famous 
chess grandmaster ... He describes a situation 
when a player thinks very hard for a long 
time [about] a complicated position but 
does not find a clear path, then, running 
low on time, quickly makes a poor move, 
often a blunder.’ Van Niekerk maintains 
that Netcare’s broad strategy is to force the 
Commission to delay the inquiry for as long 
as possible and, because of the long delay, 
cause the Commission to move quickly. 
He says KPMG’s work for Netcare was 
‘technical’ in nature.
KPMG: Netcare ‘hiding 
something’
Court papers reveal that the Commission 
suspects that Netcare wants to hide 
something. The Commission says: ‘Netcare 
also fears that information provided to the 
inquiry may lead the commission to initiate 
a complaint against it or refer it to the 
tribunal.’ The tribunal has the power to 
both subpoena evidence and fine companies 
10% of their annual turnover for price-
fixing or illegal anti-competitive behaviour. 
Commission spokesperson Trudie Makhaya 
told Izindaba that any fines would be a 
byproduct of the wider investigation, which 
was aimed at ‘bigger competition policy 
problems’. ‘If we suspect price fixing we can 
open a new probe and run with it (via the 
Competition Tribunal), imposing penalties, 
but that’s not our primary purpose.’
Explaining the Kotov reference, Da Costa 
told Izindaba that in 2011 Netcare engaged 
a professional external company to work 
with its management to assess strategy in 
the context of various possible future South 
African healthcare scenarios. They had 
used chessboard analogies to depict these 
scenarios, named Kotov, Stalemate, Gambit 
and Grandmaster. In the UK, where Netcare 
provides substantial services to the National 
Health Service set-up, this scenario planning 
was analysed in the context of the Olympics 
soon to be hosted in London (scenario 
analogies being Gold, Silver, Bronze and Off 
the Podium).
‘The local Kotov scenario was not a 
response to the more recently announced 
market inquiry here. KPMG are simply 
seeking to deflect attention away from their 
own inappropriate behaviour by making 
unfounded allegations,’ she said. The 
name ‘Project Kotov’ arose from Netcare’s 
constructive engagement with various 
external stakeholders, including senior 
government officials, politicians, academics, 
opinion formers and business executives, 
with the aim of stimulating ideas on how to 
increase access to quality healthcare in South 
Africa. The ‘Kotov scenario’ was intended 
to reflect a potential narrative of economic 
growth, but low social cohesion – with the 
likelihood of additional regulation perceived 
to be relatively high.
‘The issue has nothing to do with the 
Competitions Commission. It’s actually about 
a professional services firm (KPMG) and its 
client. It’s about the breach of good faith and 
the duty of care a professional services firm 
has to its client. It’s unacceptable behaviour, 
and we’ll protect our proprietary information 
and intellectual capital in the interests of 
Netcare and its shareholders,’ she added.
Commission aims to 
restore order to ‘law of 
the jungle’ market
Amended legislation for the first time gives 
the Commission powers of subpoena with 
attendant fines for non-co-operation – 
unlike the probe into the banking sector 
in 2008, which depended entirely on 
companies’ voluntary participation and 
resulted in some impact on bank charges but 
little change to the way banks do business. 
The health sector probe is a long-awaited 
response to a ‘law of the jungle’ situation 
that has evolved in the unevenly regulated 
private sector where, among other things, 
specialists can charge up to 500% of medical 
aid prices and patients must cough up the 
payment shortfall, in addition to their ever-
rising medical aid subscriptions. Medical 
schemes argue that they are unable to act in 
the best interests of their members because 
of their lack of bargaining power relative to 
the powerful hospital groups (a controversial 
Competitions Commission ruling in 2005, 
aimed at preventing collective price setting 
without any regulatory oversight, halted 
price negotiations between the Board 
of Healthcare Funders, the Hospitals 
Association of South Africa and the South 
African Medical Association). New research 
by economics consultancy Econex on the 
market concentration of private hospitals, 
medical schemes and administrators 
purports to show that, contrary to concerns 
over growing concentration, the private 
hospitals market has in fact remained 
flat since price negotiations were banned. 
Econex said it had constructed a bed 
database that allowed it to calculate market 
share accurately, and found that most 
consolidation in the hospital market took 
place before the ban.
Setting tariff guidelines 
– no consensus
With the Health Professions Council of South 
Africa and the national health department 
reluctant to grasp the volatile issue of setting 
patient tariff guidelines, stakeholders have 
been operating in a void with, among other 
legal battles, court applications seeking the 
‘proper’ legal interpretation of ‘pay in full’ 
for Prescribed Minimum Benefits bogging 
down in technicalities. It’s become a ‘zero-
sum game’, with each stakeholder operating 
at the expense of the other and the patient 
all but forgotten in the mix. As medical 
inflation soars, medical aids blame collusion 
between specialists and private hospitals, 
plus complicity between patients and doctors 
in abusing hospital plans. They cite the 
explosion of powerful but expensive new 
medicines and technologies and the fee-for-
service payment system, plus the fragmented 
structure in which doctors, hospitals and all 
other providers work in silos, with almost 
no co-ordination between them. Specialists, 
on their side, point to almost intolerable 
workloads resulting from serious shortages 
in their numbers, rampant brokerage and 
administration and managed-care costs in 
medical aids, plus soaring litigation insurance 
costs. It’s a toxic, society-unfriendly mix that 
has placed huge pressure on the Competitions 
Commission to come up with provisional 
findings and recommendations by its target 
date of October 2015.
Briefing stakeholders in mid-May, the 
Chairman of the Health Inquiry, former 
Chief Justice Sandile Ngcobo, said that 
its success was inextricably linked to the 
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open and transparent airing of views and 
information. He said his hand-picked team 
of experts was developing a set of ideas 
about how harmful effects of competition 
might arise in the relevant markets. Dubbed 
‘theories of harm’, these were hypotheses 
or tools enabling them to identify whether 
there were features that might prevent, 
distort or restrict competition in the private 
healthcare markets. He emphasised that 
theories of harm were not findings of harm, 
but simply analytical tools to guide analysis. 
‘They will be deepened and revised as the 
inquiry’s thinking develops,’ he added. Harm 
to competition could come from market 
power, including market concentration, 
barriers to entry and expansion, imperfect 
information, regulatory framework and 
vertical relationships. Judge Ngcobo said 
the issuing of ‘information requests’ would 
be done by August this year. The first round 
of public hearings would be held between 
1 March and 30 April next year. Beginning 
in May next year, the inquiry would analyse 
and review all information gathered, putting 
provisional findings and recommendations 
out for public comment by October 2015. 
Quizzed on how the Netcare court challenge 
to its auditors might affect these timelines, 
Competitions Commissioner Tembinkosi 
Bonakele would only say that ‘the probe 
is live and happening, just slower than 
anticipated’.
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